Latham & Watkins Advises TPG Capital in Majority Investment in Confluent Medical Technologies
Confluent Medical Technologies (Confluent), a leading materials science, development, and manufacturing partner to medical device manufacturers, has announced the closing of a majority investment from TPG Capital, the private equity platform of alternative asset management firm TPG.
Latham & Watkins LLP represented TPG Capital in the transaction with a deal team led by Boston/Chicago private equity M&A partners Neal J. Reenan and Ian Bushner, with associates Madisson Goorman, Karysa Norris, Jase Burner, Jennifer Boyd, and Jake Wasserman, and a private equity finance team led by Washington, D.C./New York partner Manu Gayatrinath and associate Jennifer Kent, with associates Zachary Anderson, Dalton Downing, and Zach Lippman. Advice was also provided on tax matters by Bay Area partner Katharine Moir, with associate Alex Farris; on FDA regulatory matters by Washington, D.C. partner Ben Haas, with associate Seth Olson; on healthcare regulatory matters by Washington, D.C. counsel Nicole Liffrig Molife, with associate Margaret Rote; on product liability matters by Washington, D.C. partner Allen Gardner; on intellectual property matters by Washington, D.C. partner Jeremiah Wolsk, with associate Ryan Sanders; on data privacy matters by Bay Area counsel Robert Blamires, with associate Adriana Beach; on benefits and compensation matters by New York partner Jennifer Pepin, with associate Jina Davidovich; on real estate matters by Chicago counsel Jeffrey Anderson; on environmental matters by Washington. D.C. partner James Barrett, with associate Phil Sandick; on anti-corruption matters by Chicago partner Meredith Monroe, with associate Joseph Grosser; on representation and warranty insurance matters by Los Angeles partner Drew Levin, with associate Harrison White; and on capital markets matters by Boston partner Elisabeth Martin.